Video Replays

Session I: COVID-19 – Respiratory Challenge
Presentations Received

  • Talk 1.1: The Challenge of COVID-19
  • Talk 1.2: Strategies to Avoid Mechanical Ventilation
  • Talk 1.3: ARDS Management in COVID-19
  • Talk 1.4: Role of ECMO in COVID-19

Session II: COVID-19 – Multiorgan Challenge
Presentations Received

  • Talk 2.1: Combatting the Coagulopathy in COVID-19
  • Talk 2.2: Cardiac Manifestations of COVID-19
  • Talk 2.3: Acute Kidney Injury and COVID-19
  • Talk 2.4: Multisystem Inflammatory Syndrome in Children

Session III: COVID 3 – Therapeutics
Presentations Received

  • Talk 3.1: The Role for Steroids in COVID-19
  • Talk 3.2: When to Use Remdesivir in COVID-19
  • Talk 3.3: Convalescent Plasma in COVID-19
  • Talk 3.4: Promising Therapeutics on the Horizon

Session IV: Cardiac
Presentations Received

  • Talk 4.1: Catheter Directed Therapy for Massive Pulmonary Embolism
  • Talk 4.2: Cardiac Arrest: Role for ECMO in 2020
  • Talk 4.3: Acute Right Ventricular Failure
  • Talk 4.4: Wide Complex Tachycardia in the ICU- Now What?

Session V: Neurocritical Care
Presentations Received

  • Talk 5.1: Recent Advances for Thrombolytics for Ischemic Stroke
  • Talk 5.2: Upcoming Advances for Intracerebral Hemorrhage
  • Talk 5.3: Managing Delirium & Encephalopathy in COVID
  • Talk 5.4: Determining Brain Death

Session VI: Sepsis
Presentations Received

  • Talk 6.1: Rapid Diagnostics and the Syndromic Approach to Sepsis
  • Talk 6.2: Biomarkers to Guide Antibiotic Therapy
  • Talk 6.3: How I Use Lactate and SCVO2 in Sepsis Resuscitation
  • Talk 6.4: POCUS is the Key to Sepsis Resuscitation
  • Talk 6.5: Refractory Septic Shock – Vasoplegia Strategies

Session VII: Gastrointestinal
Presentations Received

  • Talk 7.1: When to Call the Surgeon for Acute Pancreatitis
  • Talk 7.2: Management of Esophageal Perforation
  • Talk 7.3: Graft Dysfunction after Liver Transplantation
  • Talk 7.4: C Diff Colitis – Diagnosis and Optimal Management

Session VIII: Renal
Presentations Received

  • Talk 8.1: Are Biomarkers Ready for Prime Time in Acute Kidney Injury
  • Talk 8.2: How I Choose Between RRT Modalities for AKI
  • Talk 8.3: Can Contrast Nephropathy Be Prevented?
  • Talk 8.4: How I Approach AKI in the Heart & Lung Transplant patient?

Session IX: ICU Systems
Presentations Received

  • Talk 9.1: The Evolving Role of Decision Support in the ICU
  • Talk 9.2: Telemedicine in the ICU
  • Talk 9.3: How the COVID Experience will transform ICU Care
  • Talk 9.4: Collaboration across the Texas Medical Center
  • Talk 9.5: Five Key Takeaways from the COVID Experience
  • Talk 9.6: How Close Are We To A Vaccine for COVID-19

Session X: Trauma
Presentations Received

  • Talk 10.1: Abdominal Compartment Syndrome: Is it Relevant in 2020?
  • Talk 10.2: Surgical Rib Fixation: Panacea or False Hope
  • Talk 10.3: The Utility of Tranexamic Acid (TXA)
  • Talk 10.4: Timing of DVT Prophylaxis in Solid Organ, Spine, and Traumatic Brain Injury

Session XI: Potpourri (Heme, Nutrition, Endocrine)
Presentations Received

  • Talk 11.1: Enteral, Parenteral, or Both – How to Feed?
  • Talk 11.2: Optimal Management of Adrenal Insufficiency?
  • Talk 11.3: The Bleeding Patient on DOACS. Now What?
  • Talk 11.4: Systematic Approach to Thrombocytopenia in the ICU

Session XII: The Hard Discussions (Chatterjee, Guntapalli)
Presentations Received

  • Talk 12.1: Staff Well Being – COVID and Beyond
  • Talk 12.2: The Post Intensive Care Syndrome after COVID
  • Talk 12.3: The Good, the Bad, and the Ugly of End-of-Life Decisions
  • Talk 12.4: The Difference between a Good and Great Intensivist – Nursing Perspective
  • Talk 12.5: The Difference between a Good and Great Intensivist – Respiratory Therapist Perspective
  • Talk 12.6: The Difference between a Good and Great Intensivist – Pharmacy Perspective